Professor Alan Boyd
senior medical consultant
Professor Alan Boyd BSc, MB ChB, FRSB, FRCP, FFPM
Professor Boyd is a Fellow and immediate past-President of the Faculty of Pharmaceutical Medicine, Royal College of Physicians.
He holds degrees in biochemistry and medicine from the University of Birmingham.
In his industry career, he has worked for Glaxo and ICI/Zeneca, where he became the Global Head of Medical Research and subsequently was R&D Director for Ark Therapeutics Ltd where he pioneered the development of gene-based medicines.
He is now CEO of Boyd Consultants which supports early stage life-science companies and universities in the development of their medicinal products.
He is also an Honorary Professor at the University of Birmingham Medical School, in recognition of his expertise in medicines development. In April 2018, he was also elected as a Fellow of the Royal College of Physicians, London.